4B34
Humanised monomeric RadA in complex with 2-amino benzothiazole
Summary for 4B34
Entry DOI | 10.2210/pdb4b34/pdb |
Related | 1PZN 4A6P 4A6X 4A74 4A7O 4B2I 4B2L 4B2P 4B32 4B33 4B35 |
Descriptor | DNA REPAIR AND RECOMBINATION PROTEIN RADA, PHOSPHATE ION, 1,3-benzothiazol-2-amine, ... (4 entities in total) |
Functional Keywords | hydrolase, recombinase, thermostable, peptide-binding |
Biological source | PYROCOCCUS FURIOSUS |
Total number of polymer chains | 1 |
Total formula weight | 25747.32 |
Authors | Scott, D.E.,Ehebauer, M.T.,Pukala, T.,Marsh, M.,Blundell, T.L.,Venkitaraman, A.R.,Abell, C.,Hyvonen, M. (deposition date: 2012-07-20, release date: 2013-02-06, Last modification date: 2023-12-20) |
Primary citation | Scott, D.E.,Ehebauer, M.T.,Pukala, T.,Marsh, M.,Blundell, T.L.,Venkitaraman, A.R.,Abell, C.,Hyvonen, M. Using a Fragment-Based Approach to Target Protein-Protein Interactions. Chembiochem, 14:332-, 2013 Cited by PubMed Abstract: The ability to identify inhibitors of protein-protein interactions represents a major challenge in modern drug discovery and in the development of tools for chemical biology. In recent years, fragment-based approaches have emerged as a new methodology in drug discovery; however, few examples of small molecules that are active against chemotherapeutic targets have been published. Herein, we describe the fragment-based approach of targeting the interaction between the tumour suppressor BRCA2 and the recombination enzyme RAD51; it makes use of a screening pipeline of biophysical techniques that we expect to be more generally applicable to similar targets. Disruption of this interaction in vivo is hypothesised to give rise to cellular hypersensitivity to radiation and genotoxic drugs. We have used protein engineering to create a monomeric form of RAD51 by humanising a thermostable archaeal orthologue, RadA, and used this protein for fragment screening. The initial fragment hits were thoroughly validated biophysically by isothermal titration calorimetry (ITC) and NMR techniques and observed by X-ray crystallography to bind in a shallow surface pocket that is occupied in the native complex by the side chain of a phenylalanine from the conserved FxxA interaction motif found in BRCA2. This represents the first report of fragments or any small molecule binding at this protein-protein interaction site. PubMed: 23344974DOI: 10.1002/CBIC.201200521 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.55 Å) |
Structure validation
Download full validation report